Projects per year
Search results
-
Active
A Randomized, Double-Blind, Placebo-Controlled Study of ATH434 in Multiple Systems Atrophy
18/10/22 → 1/10/24
Project: Research
-
Randomized, double-blind, placebo-controlled, multiple dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of YTX-7739, a novel oral inhibitor of Stearoyl-CoA-desaturases, in patients with Parkinson's Disease
Bertram, K. & Kerris, J.
1/06/21 → 31/12/23
Project: Research
-
An Open-label Extension of Study M15-736 to Evaluate the Safety and Tolerability of 24-hour Daily Exposure of ABBV-951 in Subjects with Advanced Parkinson's Disease.
Bertram, K. & Burn, K.
20/10/20 → 31/12/24
Project: Research
-
An open-label extension of Study M15-741 to evaluate the safety and tolerability of 24-hour daily exposure of continuous subcutaneous infusion of ABBV-951 in subjects with Parkinson's disease.
Bertram, K., Fung, V. S. C., Hayes, M., Stell, R., Kimber, T. E. & Bonke, V.
6/10/20 → 31/12/25
Project: Research
-
Sodium Selenate as a Disease Modifying Treatment for Progressive Supranuclear Palsy (Sodium Selenate for PSP)
O'Brien, T., Bertram, K., Vivash, L., Evans, A. H., Kimber, T. E., O'Sullivan, J. D., Malpas, C., Fielding, J., Velakoulis, D. & Law, M.
1/06/20 → 31/05/25
Project: Research
-
A Phase 2 Clinical Trial Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of PRAX-944 in Adults with Essential Tremor.
Bertram, K., Fung, V. S. C., Lehn, A., Evans, A. H., Kotschet, K., Heshmat, S., Pepper, E. M. & Burn, K.
1/06/19 → 31/12/24
Project: Research
-
Clinical Study No. M15-563, An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP).
Bertram, K. & Burn, K.
3/04/19 → 30/04/24
Project: Research